Results 171 to 180 of about 132,280 (264)

Oral Deucravacitinib for Treatment-Refractory Cutaneous Lupus Erythematosus. [PDF]

Cureus
Matthew EJ, Verma KK, Paulger B.
europepmc   +1 more source

Exacerbation of bullous systemic lupus erythematosus with erythema gyratum repens-like pattern following dupilumab. [PDF]

JAAD Case Rep
Santiago Mangual KP, Truong A, Mo J, Liu J, Khaligi MA, Haussmann A, Razmjou AA, Holland V, Cheng K.   +8 more
europepmc   +1 more source

Atypical infections during combination therapy with anifrolumab and other immunosuppressives in patients with lupus erythematosus: A case series. [PDF]

J Dtsch Dermatol Ges
Chambers S, Gomes LLA, Yang X, On A, Ali H, Khosravi-Hafshejani T, DeQuattro K, Thomas P, Werth VP.   +8 more
europepmc   +1 more source

Involvement of the mouth and jaw area in dermatological diseases. [PDF]

GMS Hyg Infect Control
Ramiah V, Sankar SL, Shunmugavelu K, Hussain ST, Sadasivam MP, Behura SS.   +5 more
europepmc   +1 more source

Flare of bullous lupus erythematosus in patients treated with anifrolumab for discoid lupus erythematosus: 2 cases. [PDF]

JAAD Case Rep
Lesort C, Breton AL, Wirbel C, Durel CA, Chastagner M, Ribereau-Gayon E, Hot A, Kanitakis J.   +7 more
europepmc   +1 more source

The identification of a novel splicing mutation in in a Japanese family with C1q deficiency: a case report [PDF]

core   +1 more source

Establishment of a Multidisciplinary Pediatric Lupus Care Clinic at a Tertiary Center. [PDF]

J Multidiscip Healthc
Meidan E, Daga A, Mcdonough A, Biancarelli M, Dorsey CM, Dekermanji A, Esty B, Son MB, Hazen M.   +8 more
europepmc   +1 more source